CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancer

[1]  A. Berchuck,et al.  Histotype classification of ovarian carcinoma: A comparison of approaches. , 2018, Gynecologic oncology.

[2]  Dai-qiang Li,et al.  Association of chloride intracellular channel 4 and Indian hedgehog proteins with survival of patients with pancreatic ductal adenocarcinoma , 2016, International journal of experimental pathology.

[3]  Jia-Tong Xu,et al.  Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics , 2016, Oncotarget.

[4]  M. Mann,et al.  Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status , 2016, Nature Communications.

[5]  Bryn Nelson,et al.  To Screen or Not to Screen? , 2023, Endocrinology and metabolism.

[6]  S. Leung,et al.  An Immunohistochemical Algorithm for Ovarian Carcinoma Typing , 2016, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[7]  S. Dong,et al.  CLIC1 overexpression is associated with poor prognosis in pancreatic ductal adenocarcinomas. , 2016, Journal of cancer research and therapeutics.

[8]  Yehai Liu,et al.  Knockdown of CLIC4 enhances ATP-induced HN4 cell apoptosis through mitochondrial and endoplasmic reticulum pathways , 2016, Cell & Bioscience.

[9]  P. Kroeger,et al.  Pathogenesis and heterogeneity of ovarian cancer , 2016, Current opinion in obstetrics & gynecology.

[10]  M. Faretta,et al.  Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth , 2015, Oncotarget.

[11]  Z. Wang,et al.  Chloride intracellular channel 1 (CLIC1) is activated and functions as an oncogene in pancreatic cancer , 2015, Medical Oncology.

[12]  Yuguang Ye,et al.  CLIC1 a novel biomarker of intraperitoneal metastasis in serous epithelial ovarian cancer , 2015, Tumor Biology.

[13]  Jinjian Yang,et al.  Chloride intracellular channel 1 regulates prostate cancer cell proliferation and migration through the MAPK/ERK pathway. , 2014, Cancer biotherapy & radiopharmaceuticals.

[14]  X. Bian,et al.  CLIC4, ERp29, and Smac/DIABLO Derived from Metastatic Cancer Stem–like Cells Stratify Prognostic Risks of Colorectal Cancer , 2014, Clinical Cancer Research.

[15]  Y. Hao,et al.  Chloride intracellular channel 1 regulates colon cancer cell migration and invasion through ROS/ERK pathway. , 2014, World journal of gastroenterology.

[16]  K. Ohashi,et al.  Proteome Analysis for Downstream Targets of Oncogenic KRAS - the Potential Participation of CLIC4 in Carcinogenesis in the Lung , 2014, PloS one.

[17]  S. Zhang,et al.  Chloride intracellular channel 1 is overexpression in hepatic tumor and correlates with a poor prognosis , 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[18]  D. Speicher,et al.  Protein isoform-specific validation defines multiple chloride intracellular channel and tropomyosin isoforms as serological biomarkers of ovarian cancer. , 2013, Journal of proteomics.

[19]  C. Sander,et al.  Evaluating cell lines as tumour models by comparison of genomic profiles , 2013, Nature Communications.

[20]  D. Speicher,et al.  Identification of Multiple Novel Protein Biomarkers Shed by Human Serous Ovarian Tumors into the Blood of Immunocompromised Mice and Verified in Patient Sera , 2013, PloS one.

[21]  Hongyu Zhang,et al.  Inhibition of CLIC4 Enhances Autophagy and Triggers Mitochondrial and ER Stress-Induced Apoptosis in Human Glioma U251 Cells under Starvation , 2012, PloS one.

[22]  G. Gao,et al.  Elevated expression of chloride intracellular channel 1 is correlated with poor prognosis in human gliomas , 2012, Journal of experimental & clinical cancer research : CR.

[23]  Anjali Shukla,et al.  CLIC4 is a tumor suppressor for cutaneous squamous cell cancer. , 2012, Carcinogenesis.

[24]  Z. Szallasi,et al.  Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. , 2012, Endocrine-related cancer.

[25]  P. Gimotty,et al.  A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer. , 2012, Journal of proteome research.

[26]  Z. Szallasi,et al.  P1-07-18: Expanding an Online Tool for Genome-Wide Validation of Survival-Associated Biomarkers in Breast and Ovarian Cancer Using Microarray Data of 3,862 Patients. , 2011 .

[27]  D. Speicher,et al.  Data analysis strategy for maximizing high-confidence protein identifications in complex proteomes such as human tumor secretomes and human serum. , 2011, Journal of proteome research.

[28]  Sudhir Srivastava,et al.  A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer , 2011, Cancer Prevention Research.

[29]  Sudhir Srivastava,et al.  Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens , 2011, Cancer Prevention Research.

[30]  Steven J Skates,et al.  Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. , 2010, American journal of obstetrics and gynecology.

[31]  D. Fishman,et al.  Biomarkers for ovarian cancer detection and therapy , 2010, Cancer biology & therapy.

[32]  L. Frati,et al.  HE4: a new potential early biomarker for the recurrence of ovarian cancer , 2010, Tumor Biology.

[33]  D. Clarke‐Pearson,et al.  Screening for Ovarian Cancer , 2009 .

[34]  M. Wei,et al.  CLIC4 mediates TGF-beta1-induced fibroblast-to-myofibroblast transdifferentiation in ovarian cancer. , 2009, Oncology reports.

[35]  D. Mutch.  Ovarian cancer: to screen or not to screen. , 2009, Obstetrics and gynecology.

[36]  S. Leung,et al.  Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies , 2008, PLoS medicine.

[37]  Feng Su,et al.  The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125? , 2008, American journal of obstetrics and gynecology.

[38]  A. Sood,et al.  The ROC 'n' role of the multiplex assay for early detection of ovarian cancer , 2008, Nature Clinical Practice Oncology.

[39]  D. Ward,et al.  Diagnostic Markers for Early Detection of Ovarian Cancer , 2008, Clinical Cancer Research.

[40]  Daniel W Chan,et al.  Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer. , 2007, Gynecologic oncology.

[41]  A. Oshima,et al.  Reciprocal Modifications of CLIC4 in Tumor Epithelium and Stroma Mark Malignant Progression of Multiple Human Cancers , 2007, Clinical Cancer Research.

[42]  M. Suchard,et al.  Validation of Candidate Serum Ovarian Cancer Biomarkers for Early Detection , 2007, Biomarker insights.

[43]  K A Baggerly,et al.  New tumor markers: CA125 and beyond , 2005, International Journal of Gynecologic Cancer.

[44]  M. Dimopoulos,et al.  Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience. , 2005, Gynecologic oncology.

[45]  William L. Bigbee,et al.  Multiplexed Immunobead-Based Cytokine Profiling for Early Detection of Ovarian Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[46]  T. Reynolds,et al.  The role of CA125 in clinical practice , 2005, Journal of Clinical Pathology.

[47]  M. Gerdes,et al.  Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor {alpha}-induced apoptosis, and inhibits tumor growth. , 2005, Cancer research.

[48]  S. Skates,et al.  Blood and Urine Markers for Ovarian Cancer: A Comprehensive Review , 2004, Disease markers.

[49]  R. Bast,et al.  Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer , 2004, Cancer Research.

[50]  K. Nagashima,et al.  The Organellular Chloride Channel Protein CLIC4/mtCLIC Translocates to the Nucleus in Response to Cellular Stress and Accelerates Apoptosis* , 2004, Journal of Biological Chemistry.

[51]  O. Petersen,et al.  Differential expression of a chloride intracellular channel gene, CLIC4, in transforming growth factor-beta1-mediated conversion of fibroblasts to myofibroblasts. , 2002, The American journal of pathology.

[52]  D. Mutch.  Surgical management of ovarian cancer. , 2002, Seminars in oncology.

[53]  S. Cannistra.  Cancer of the ovary. , 1993, The New England journal of medicine.

[54]  R. Bast,et al.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. , 1983, The New England journal of medicine.

[55]  R. Bast,et al.  Reactivity of a monoclonal antibody with human ovarian carcinoma. , 1981, The Journal of clinical investigation.

[56]  H. Weng,et al.  CLIC1 overexpression is associated with poor prognosis in gallbladder cancer , 2014, Tumor Biology.

[57]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[58]  R. Bast,et al.  Validation of Biomarker Panels for Ovarian Cancer A Framework for Evaluating Biomarkers for Early Detection : Updated , 2011 .

[59]  Henry E. Kyburg,et al.  Comparison of Approaches , 1974 .

[60]  N. Dubrawsky.  Cancer statistics , 2022 .